LATHAM, N.Y.--(BUSINESS WIRE)--Dec. 11, 2017--
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative,
minimally invasive medical devices for vascular access, surgery,
peripheral vascular disease and oncology, today announced that it will
report financial results for the second quarter of fiscal year 2018
before the market open on Thursday, January 4, 2018. The Company’s
management will host a conference call at 8:00 a.m. ET that same day to
discuss the results.
To participate in the conference call, dial 877-407-0784 (domestic) or
201-689-8560 (international) and refer to the passcode 13674426.
This conference call will also be webcast and can be accessed from the
“Investors” section of the Company’s website at www.angiodynamics.com.
The webcast replay of the call will be available at the same site
approximately one hour after the end of the call.
A recording of the call will also be available from 11:00 a.m. ET on
Thursday, January 4, 2018, until 11:59 p.m. ET on Thursday, January 11,
2018. To hear this recording, dial 844-512-2921 (domestic) or
412-317-6671 (international) and enter the passcode 13674426.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally
invasive medical devices used by professional healthcare providers for
vascular access, surgery, peripheral vascular disease and oncology.
AngioDynamics’ diverse product lines include market-leading ablation
systems, fluid management systems, vascular access products,
angiographic products and accessories drainage products, thrombolytic
products and venous products. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171211005978/en/
Source: AngioDynamics, Inc.
Executive Vice President & CFO